Showing results (151-160 of 222) with videos related to
Sort By:
Pageof 23
Urologic Oncology|June 6, 2022
Identification of potential biomarkers and novel therapeutic targets through genomic analysis of small cell bladder carcinoma and associated clinical outcomesEarle F Burgess, J Alexa Sanders, Chad Livasy, et al.Investigational New Drugs|February 28, 2006
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinomaElisabeth I Heath, Barbara A Burtness, Lawrence Kleinberg, et al.Human Genetics|July 2, 2009
Results from a prostate cancer admixture mapping study in African-American menCathryn Hufford Bock, Ann G Schwartz, Julie J Ruterbusch, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 18, 2018
Tissue-specific regulation of cytochrome c by post-translational modifications: respiration, the mitochondrial membrane potential, ROS, and apoptosisHasini A Kalpage, Viktoriia Bazylianska, Maurice A Recanati, et al.Cancer Research|March 15, 2008
Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibitionDuyen T Dang, Sang Y Chun, Kyunghee Burkitt, et al.Cancer Chemotherapy and Pharmacology|January 15, 2013
A phase 2 study of KX2-391, an oral inhibitor of Src kinase and tubulin polymerization, in men with bone-metastatic castration-resistant prostate cancerEmmanuel S Antonarakis, Elisabeth I Heath, Edwin M Posadas, et al.Journal for Immunotherapy of Cancer|May 16, 2014
Recombinant interleukin-21 plus sorafenib for metastatic renal cell carcinoma: a phase 1/2 studyShailender Bhatia, Brendan Curti, Marc S Ernstoff, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2016
A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local TherapyRana R McKay, Amado J Zurita, Lillian Werner, et al.Cancer Research Communications|June 10, 2024
Race-Related Differences in Sipuleucel-T Response among Men with Metastatic Castrate-Resistant Prostate CancerElisabeth I Heath, Archana Thakur, Wei Chen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 21, 2026
B7-H3 Gene Expression Shapes Prognosis and Therapeutic Opportunities Across Prostate Cancer Patient GroupsAllison Makovec, Ava P Gustafson, Nishant Gandhi, et al.Pageof 23